1 903 206 EFFECTIVENESS OF A YOGA-BASED LIFESTYLE PROTOCOL (YLP) IN PREVENTING DIABETES IN A HIGH-RISK INDIAN COHORT: A MULTICENTER CLUSTER-RANDOMIZED CONTROLLED TRIAL (NMB-TRIAL). INTRODUCTION: THOUGH SEVERAL LINES OF EVIDENCE SUPPORT THE UTILITY OF YOGA-BASED INTERVENTIONS IN DIABETES PREVENTION, MOST OF THESE STUDIES HAVE BEEN LIMITED BY METHODOLOGICAL ISSUES, PRIMARILY SAMPLE SIZE INADEQUACY. HENCE, WE TESTED THE EFFECTIVENESS OF YOGA-BASED LIFESTYLE INTERVENTION AGAINST DIABETES RISK REDUCTION IN MULTICENTRE, LARGE COMMUNITY SETTINGS OF INDIA, THROUGH A SINGLE-BLIND CLUSTER-RANDOMIZED CONTROLLED TRIAL, NIYANTRITA MADHUMEHA BHARAT ABHIYAN (NMB). RESEARCH DESIGN AND METHODS: NMB-TRIAL IS A MULTICENTRE CLUSTER-RANDOMIZED TRIAL CONDUCTED IN 80 CLUSTERS [COMPOSED OF RURAL UNITS (VILLAGES) AND URBAN UNITS (CENSUS ENUMERATION BLOCKS)] RANDOMLY ASSIGNED IN A 1:1 RATIO TO INTERVENTION AND CONTROL GROUPS. PARTICIPANTS WERE INDIVIDUALS (AGE, 20-70 YEARS) WITH PREDIABETES (BLOOD HBA1C VALUES IN THE RANGE OF 5.7-6.4%) AND IDRS >/= 60. THE INTERVENTION INCLUDED THE PRACTICE OF YOGA-BASED LIFESTYLE MODIFICATION PROTOCOL (YLP) FOR 9 CONSECUTIVE DAYS, FOLLOWED BY DAILY HOME AND WEEKLY SUPERVISED PRACTICES FOR 3 MONTHS. THE CONTROL CLUSTER RECEIVED STANDARD OF CARE ADVICE FOR DIABETES PREVENTION. STATISTICAL ANALYSES WERE PERFORMED ON AN INTENTION-TO-TREAT BASIS, USING AVAILABLE AND IMPUTED DATASETS. THE PRIMARY OUTCOME WAS THE CONVERSION FROM PREDIABETES TO DIABETES AFTER THE YLP INTERVENTION OF 3 MONTHS (DIAGNOSED BASED UPON HBA1C CUTOFF >6.5%). SECONDARY OUTCOME INCLUDED REGRESSION TO NORMOGLYCEMIA WITH HBA1C <5.7%. RESULTS: A TOTAL OF 3380 (75.96%) PARTICIPANTS WERE FOLLOWED UP AT 3 MONTHS. AT 3 MONTHS POST-INTERVENTION, OVERALL, DIABETES DEVELOPED IN 726 (21.44%) PARTICIPANTS. YLP WAS FOUND TO BE SIGNIFICANTLY EFFECTIVE IN HALTING PROGRESSION TO DIABETES AS COMPARED TO STANDARD OF CARE; ADJUSTED RRR WAS 63.81(95% CI = 56.55-69.85). THE YLP ALSO ACCELERATED REGRESSION TO NORMOGLYCEMIA [ADJUSTED ODDS RATIO (ADJOR) = 1.20 (95% CI, 1.02-1.43)]. IMPORTANTLY, YOUNGER PARTICIPANTS (0.05). YOGA IMPROVED GLYCEMIC OUTCOMES AND OTHER RISK FACTORS FOR COMPLICATIONS IN ADULTS WITH T2DM RELATIVE TO A CONTROL CONDITION. ADDITIONAL STUDIES WITH LONGER FOLLOW-UPS ARE NEEDED TO DETERMINE THE LONG-TERM EFFICACY OF YOGA FOR ADULTS WITH T2DM. 2017 3 1805 44 PREVALENCE OF TYPE 2 DIABETES AMONG YOGA PRACTITIONERS: A PILOT CROSS-SECTIONAL STUDY IN TWO DISTRICTS IN INDIA. INTRODUCTION: DIABETES IS ONE OF THE MAJOR HEALTH DISEASES IN THE WORLD TODAY. THE EFFICACY OF YOGA IN THE MANAGEMENT OF TYPE 2 DIABETES IS WELL-ESTABLISHED. THE AIM OF THIS STUDY WAS TO ASSESS THE PREVALENCE OF TYPE 2 DIABETES AMONG YOGA PRACTITIONERS IN TWO DISTRICTS OF INDIA (ONE EACH IN WEST AND SOUTH OF INDIA). METHODOLOGY: IN THIS CROSS-SECTIONAL FIELD STUDY, 155 YOGA PRACTITIONERS FROM PUNE AND 192 FROM ERNAKULAM DISTRICTS WERE ASSESSED USING THE DIABETES RISK TEST AND FASTING BLOOD SUGAR. THE DATA COLLECTED WERE ENTERED IN A STATISTICS SOFTWARE PACKAGE AND ANALYZED USING THE PEARSON'S CORRELATION ANALYSIS, T-TEST, UNIVARIATE ANOVA, AND LINEAR REGRESSION TO UNDERSTAND THE PREDICTORS OF RISK FOR DIABETES. RESULTS: THE OVERALL PREVALENCE OF DIABETES AMONG YOGA PRACTITIONERS IN CENTRAL PUNE WAS 3.6% (95% CONFIDENCE INTERVAL [CI]: [0.01-0.04]). 18.9% OF PARTICIPANTS (95% CI: [0.16-0.19]) WERE DIAGNOSED TO BE "AT RISK" FOR DIABETES. IN ERNAKULAM, THE OVERALL PREVALENCE OF DIABETES AMONG PRACTITIONERS WAS 26% (95% CI: [0.05-0.06]) WITH 12% OF PRACTITIONERS (95% CI: [0.05-0.06]) DIAGNOSED TO BE "AT RISK" FOR DIABETES (PREDIABETIC). HIGHER AGE AND LESSER DURATION OF YOGA PRACTICE WERE SIGNIFICANT PREDICTORS OF DIABETES. CONCLUSION: IT IS ESSENTIAL FOR EVERY PERSON ABOVE THE AGE OF 40 TO UNDERGO REGULAR HEALTH CHECK-UPS AND SCREENING FOR DIABETES AND INVOLVE ONESELF IN LIFESTYLE MODIFICATION PROGRAMS SUCH AS YOGA FOR SIGNIFICANTLY LONG DURATION OF TIME ON A DAILY BASIS, TO BETTER MANAGE DIABETES. 2015 4 937 54 EFFECTIVENESS OF YOGA-BASED EXERCISE PROGRAM COMPARED TO USUAL CARE, IN IMPROVING HBA1C IN INDIVIDUALS WITH TYPE 2 DIABETES: A RANDOMIZED CONTROL TRIAL. BACKGROUND: THIS STUDY WAS DESIGNED TO EVALUATE THE EFFECTIVENESS OF A YOGA-BASED EXERCISE PROGRAM (YBEP) IN IMPROVING GLYCEMIC CONTROL IN PEOPLE WITH TYPE 2 DIABETES MELLITUS. MATERIALS AND METHODS: PATIENTS ON STABLE ORAL GLUCOSE-LOWERING AGENTS FOR AT LEAST 3 MONTHS AND HBA1C 7.5%-10% WERE RANDOMIZED IN 1:1 RATIO. THE PRIMARY OUTCOME MEASURE WAS THE DIFFERENCE OF CHANGE IN MEAN HBA1C BETWEEN GROUPS. RESULTS: THE PARTICIPANTS (N = 81) HAD MEAN (+/-STANDARD DEVIATION) AGE OF 50.6 (+/-8.5) YEARS AND HBA1C OF 8.5 +/- 0.7% (68.97 +/- 7.42 MMOL/MOL). THE FOLLOW-UP DATA WERE AVAILABLE IN 96% (78/81) OF PARTICIPANTS. OF 40 PARTICIPANTS, 25 (62.5%) ATTENDED >/=75% (>/=10 OUT OF 13) OF THE SESSIONS IN YBEP. ON THE INTENTION TO TREAT ANALYSIS, A FAVORABLE REDUCTION (0.21% 95% CONFIDENCE INTERVAL [-0.34, 0.75], P = 0.454) IN HBA1C WAS SEEN IN YBEP GROUP AS COMPARED TO USUAL CARE. THE REDUCTION IN HBA1C BY >/=0.5% WAS OBSERVED IN 44.7% OF PARTICIPANTS IN YBEP AS COMPARED TO 37.5% IN USUAL CARE ARM, RESPECTIVELY. THOSE WHO ATTENDED >/=75% OF THE SESSIONS HAD BETTER HBA1C REDUCTION OF 0.3% IN COMPARISON TO 0.1% REDUCTION SEEN IN THOSE WHO ATTENDED <75% OF THE SESSIONS. CONCLUSIONS: YBEP DEMONSTRATED A CLINICALLY RELEVANT HBA1C REDUCTION COMPARED TO USUAL CARE IN PARTICIPANTS WHO HAD ATTENDED AT LEAST 75% OF THE YOGA SESSIONS. THE REDUCTION IN HBA1C BY >0.5% IN 44.7% IN THE YOGA GROUP, SUGGESTS, THAT IT CAN BE PRESCRIBED AS AN EXERCISE TO INDIVIDUALS WHO ARE UNABLE TO WALK EITHER DUE TO LIMITED JOINT MOBILITY, ADVERSE WEATHER CONDITIONS, LACK OF SPACE FOR WALKING, CULTURAL OR RELIGIOUS PROHIBITIONS FOR WOMEN FOR OUTDOOR PHYSICAL ACTIVITY, AND SO ON.CTRI REGISTRATION NO: CTRI/2017/05/008564. 2020 5 1849 50 QUASI PROSPECTIVE COMPARATIVE STUDY ON EFFECT OF YOGA AMONG PREDIABETICS ON PROGRESSION OF CARDIOVASCULAR RISK FACTORS. INTRODUCTION: PREDIABETIC PATIENTS HAVE HIGHER RISK FOR CARDIOVASCULAR DISEASES, WHICH FURTHER INCREASES THE RATE OF MORTALITY. REASON FOR THE RATE OF INCREASE MAY BE LACK OF OBSERVATION, FOLLOW-UP PROGRAMS, AND SELF-AWARENESS ABOUT THE CONDITIONS OF DISEASE. LIFESTYLE INTERVENTIONS SUCH AS YOGA CAN PROVE TO BE A BENEFICIAL NONPHARMACOLOGIC INTERVENTION IN PREVENTING PROGRESSION OF PREDIABETES TO TYPE 2 DIABETES. THIS STUDY HIGHLIGHTS IMPORTANCE OF SHORT-TERM INTERVENTION, I.E., YOGA IN PREDIABETIC PATIENTS AND USE IT AS A TOOL FOR PRIMARY PREVENTION OF DIABETES. METHODS: THIS WAS AN INTERVENTIONAL STUDY AMONG ADULTS AGED 30-50 YEARS IN RUHS COLLEGE OF MEDICAL SCIENCES AND ASSOCIATED RUKMANI DEVI BENI PRASAD JAIPURIA HOSPITAL IN JAIPUR CITY. THE DESIGN OF STUDY WAS QUASI PROSPECTIVE COMPARATIVE STUDY. A TOTAL OF 102 PREDIABETIC PATIENTS OF AGE GROUP 30-50 YEARS WERE RECRUITED FROM JAIPURIA HOSPITAL. THESE WERE DIVIDED INTO TWO GROUPS: STUDY GROUP (GROUP A, N = 51) WERE ENGAGED IN YOGA SESSION AND CONTROL GROUP (B, N = 51) NOT PERFORMED ANY YOGA SESSION. RESULTS: YOGA INTERVENTION RESULTED IN A SIGNIFICANT DECLINE IN BLOOD GLUCOSE (P < 0.001), GLYCATED HEMOGLOBIN (P < 0.01), LIPID PROFILE CHOLESTEROL (P < 0.01), TRIGLYCERIDE (P < 0.01), AND LOW-DENSITY LIPOPROTEIN (P < 0.01), BUT HIGH-DENSITY LIPOPROTEIN (P < 0.02) AND VERY LOW-DENSITY LIPOPROTEIN INCREASE (P < 0.03) BUT NOT STATISTICALLY SIGNIFICANT RELATIVE TO THE CONTROL GROUP. CONCLUSION: SHORT-TERM YOGA INTERVENTION IS HELPFUL IN THE CONTROL OF GLYCEMIC PARAMETERS LIKE BLOOD GLUCOSE, GLYCATED HEMOGLOBIN AND LIPID PROFILE IN PREDIABETIC PATIENTS. THIS PRELIMINARY STUDY INDICATES THAT A YOGA PROGRAM WOULD BE A POSSIBLE RISK REDUCTION OPTION FOR ADULTS AT HIGH RISK FOR TYPE 2 DIABETES. IN ADDITION, YOGA HOLDS PROMISE AS AN APPROACH TO REDUCING CARDIOMETABOLIC RISK FACTORS AND INCREASING EXERCISE SELF-EFFICACY FOR PREDIABETICS PERFORMING YOGA. 2019 6 2653 49 YOGA IMPROVES OCCUPATIONAL PERFORMANCE, DEPRESSION, AND DAILY ACTIVITIES FOR PEOPLE WITH CHRONIC PAIN. BACKGROUND: CHRONIC PAIN IS A COMPLEX ACCUMULATION OF PHYSICAL, PSYCHOLOGICAL, AND SOCIAL CONDITIONS, THUS INTERVENTIONS THAT ADDRESS PAIN AND PROMOTE OCCUPATIONAL PERFORMANCE ARE NEEDED. A HOLISTIC INTERVENTION, WITH MIND AND BODY COMPONENTS, IS LIKELY NECESSARY TO BEST TREAT THE COMPLEXITIES OF CHRONIC PAIN. THUS, WE DEVELOPED AND TESTED A YOGA INTERVENTION FOR PEOPLE WITH CHRONIC PAIN. OBJECTIVES: IN A RANDOMIZED CONTROL TRIAL (RCT), PARTICIPANTS WITH CHRONIC PAIN WERE RANDOMIZED TO A YOGA INTERVENTION OR USUAL CARE GROUP. BETWEEN AND WITHIN GROUP DIFFERENCES FOR PRE-AND POST-OUTCOME MEASURE SCORES WERE ASSESSED FOR: OCCUPATIONAL PERFORMANCE, COMPLETION OF ACTIVITIES, AND DEPRESSION. METHODS: PILOT RCT WITH PARTICIPANT ALLOCATION TO 8 WEEKS OF YOGA OR USUAL CARE. BOTH GROUPS RECEIVED ONGOING MONTHLY SELF-MANAGEMENT PROGRAMMING. DATA WERE COLLECTED BEFORE AND AFTER THE 8-WEEK INTERVENTION. PARTICIPANTS WERE RANDOMIZED TO YOGA OR USUAL CARE AFTER BASELINE ASSESSMENTS. DEMOGRAPHICS WERE COLLECTED AND MEASURES INCLUDED: CANADIAN OCCUPATIONAL PERFORMANCE MEASURE (COPM) TO ASSESS OCCUPATIONAL PERFORMANCE; THE 15-ITEM FRENCHAY ACTIVITIES INDEX (FAI)(ACTIVITIES); AND THE 9-ITEM PATIENT HEALTH QUESTIONNAIRE (PHQ-9) FOR DEPRESSION. INDEPENDENT T-TESTS WERE USED TO ASSESS DIFFERENCES BETWEEN GROUPS. PAIRED T-TESTS WERE USED TO ASSESS DIFFERENCES BETWEEN PRE- AND POST 8-WEEK INTERVENTION FOR BOTH THE YOGA AND THE USUAL CARE GROUPS. PERCENT CHANGE SCORES AND EFFECT SIZES WERE CALCULATED. RESULTS: 83 PEOPLE WERE RECRUITED FOR THE STUDY AND COMPLETED BASELINE ASSESSMENTS; 44 INDIVIDUALS WERE RANDOMIZED TO YOGA AND 39 TO THE CONTROL GROUP. THE AVERAGE AGE OF ALL PARTICIPANTS WAS 51.4+/-10.5 YEARS, 68% WERE FEMALE; AND 60% HAD AT LEAST SOME COLLEGE EDUCATION. THERE WERE NO SIGNIFICANT DIFFERENCES IN DEMOGRAPHICS OR OUTCOME MEASURES BETWEEN GROUPS AT BASELINE OR 8 WEEKS; HOWEVER, THE STUDY WAS NOT POWERED TO SEE SUCH DIFFERENCES. INDIVIDUALS RANDOMIZED TO THE CONTROL GROUP DID NOT SIGNIFICANTLY IMPROVE IN ANY OUTCOME MEASURE OVER THE 8 WEEKS. THERE WERE SIGNIFICANT IMPROVEMENTS IN COPM PERFORMANCE AND COPM SATISFACTION SCORES FOR INDIVIDUALS RANDOMIZED TO THE YOGA GROUP; BOTH SCORES SIGNIFICANTLY IMPROVED. COPM PERFORMANCE IMPROVED BY 27% WITH A MODERATE TO LARGE EFFECT SIZE (3.66+/-1.85 VS 4.66+/-1.93, P < 0.001, D = 0.76). COPM SATISFACTION SIGNIFICANTLY IMPROVED BY 78% (2.14+/-2.31 VS. 3.80+/-2.50, P < 0.001) AND HAD A LARGE EFFECTS SIZE (D = 1.02). FAI SCORES IMPROVED, INDICATING INCREASED ACTIVITY OR ENGAGEMENT IN DAILY OCCUPATION DURING THE 8-WEEK INTERVENTION. SCORES INCREASED BY 5% (38.13+/-8.48 VS. 39.90+/-8.57, P = 0.024) WITH A SMALL EFFECT SIZE (D = 0.37). DEPRESSION SIGNIFICANTLY DECREASED FROM 13.21+/-5.60 TO 11.41+/-5.82, P = 0.041, WITH A SMALL EFFECT SIZE. CONCLUSION: DATA FROM THIS PILOT RCT INDICATE YOGA MAY BE AN EFFECTIVE THERAPEUTIC INTERVENTION WITH PEOPLE IN CHRONIC PAIN TO IMPROVE OCCUPATIONAL PERFORMANCE, INCREASE ENGAGEMENT IN ACTIVITIES, AND DECREASE DEPRESSION. OCCUPATIONAL THERAPY PRACTITIONERS MAY CONSIDER ADDING YOGA AS A TREATMENT INTERVENTION TO ADDRESS THE NEEDS OF PEOPLE WITH PAIN. 2019 7 930 48 EFFECTIVENESS OF YOGA PROGRAM IN THE MANAGEMENT OF DIABETES USING COMMUNITY HEALTH WORKERS IN THE URBAN SLUMS OF BANGALORE CITY: A NON-RANDOMIZED CONTROLLED TRIAL. TRIAL DESIGN: NONRANDOMIZED CONTROLLED TRIAL. METHODS: NONRANDOMIZED CONTROLLED TRIAL. THIS WAS AN INTERVENTIONAL STUDY THAT WAS CONDUCTED IN 4 SLUMS OF BENGALURU. OF THE 256 DIABETES PARTICIPANTS, ONLY 109 PEOPLE AGREED TO PARTICIPATE IN THE PROGRAM. OF 109 PEOPLE, 52 PEOPLE AGREED TO PARTICIPATE IN THE INTERVENTION (AGREED TO LEARN AND PRACTICE YOGA) WHILE THE REMAINING 57 PEOPLE WERE ASSIGNED TO NONINTERVENTION GROUP. RANDOMIZATION AND BLINDING COULD NOT BE DONE. OBJECTIVE AND OUTCOME: THE STUDY WAS CONDUCTED WITH OBJECTIVE OF ASSESSING THE EFFECTIVENESS OF YOGA, PRANAYAMA, AND SUDARSHAN KRIYA IN THE COMMUNITY-BASED MANAGEMENT OF DIABETES MELLITUS. THE PRIMARY OUTCOME VARIABLE WAS HB1AC AND SECONDARY OUTCOME VARIABLES WERE SYSTOLIC BLOOD PRESSURE (SBP), DIASTOLIC BLOOD PRESSURE (DBP), ADHERENCE TO MEDICATION, AND CHANGES IN LIFESTYLE. RESULTS: THE STUDY WAS CONDUCTED FOR 40 DAYS. COMMUNITY HEALTH WORKERS MADE A TOTAL OF 6 VISITS DURING THE STUDY. ALL THE 109 PARTICIPANTS WERE AVAILABLE FOR WEEKLY FOLLOW-UP. THERE WERE NO DROP OUTS AMONG THE STUDY POPULATION. STATISTICALLY SIGNIFICANT CHANGE WAS SEEN IN THE CONSUMPTION OF VEGETABLE (CHI(2) = 15.326, P < 0.005), FRUITS (CHI(2) = 16.207, P < 0.005), SALTY FOOD (CHI(2) = 14.823, P < 0.005), BAKERY FOOD (CHI(2) = 10.429, P < 0.005) AND FRIED FOOD (CHI(2) = 15.470, P < 0.005), ADHERENCE TO METFORMIN (CHI(2) = 41.780, P < 0.005) AND OTHER MEDICATION(CHI(2) = 21.871, P < 0.005) AND PROPORTION OF PATIENTS WITH DBP UNDER CONTROL (CHI(2) = 9.396, P < 0.005) AND PROPORTION OF PEOPLE WITH GLUCOSE RANDOM BLOOD SUGAR UNDER CONTROL (CHI(2) = 29.693, P < 0.005) BETWEEN THE TWO GROUPS FOLLOWING THE INTERVENTION. STATISTICALLY SIGNIFICANT CHANGE WAS ALSO SEEN IN THE PROPORTION OF PEOPLE WITH SBP/DBP 5%) COMPARED TO WEIGHT GAIN. RESULTS: YOGA PRACTICE FOR FOUR OR MORE YEARS WAS ASSOCIATED WITH A 3.1-LB LOWER WEIGHT GAIN AMONG NORMAL WEIGHT (BMI < 25) PARTICIPANTS [9.5 LBS VERSUS 12.6 IBS] AND AN 18.5-LB LOWER WEIGHT GAIN AMONG OVERWEIGHT PARTICIPANTS [-5.0 LBS VERSUS 13.5 IBS] (BOTH P FOR TREND <.001). AMONG OVERWEIGHT INDIVIDUALS, 4+ YEARS OF YOGA PRACTICE WAS ASSOCIATED WITH A RELATIVE ODDS OF 1.85 (95% CONFIDENCE INTERVAL [CI] 0.63-5.42) FOR WEIGHT MAINTENANCE (WITHIN 5%) AND 3.88 (95% CL 1.30-9.88) FOR WEIGHT LOSS (> 5%) COMPARED TO WEIGHT GAIN (P FOR TREND .026 AND .003, RESPECTIVELY). CONCLUSIONS: REGULAR YOGA PRACTICE WAS ASSOCIATED WITH ATTENUATED WEIGHT GAIN, MOST STRONGLY AMONG INDIVIDUALS WHO WERE OVERWEIGHT. ALTHOUGH CAUSAL INFERENCE FROM THIS OBSERVATIONAL STUDY IS NOT POSSIBLE, RESULTS ARE CONSISTENT WITH THE HYPOTHESIS THAT REGULAR YOGA PRACTICE CAN BENEFIT INDIVIDUALS WHO WISH TO MAINTAIN OR LOSE WEIGHT. 2005 15 371 30 AWARENESS AND PRACTICE OF AEROBIC EXERCISE AND YOGA AMONG HYPERTENSIVE PATIENTS IN ANAND CITY. BACKGROUND: AEROBIC EXERCISE IS HELPFUL IN REDUCING ELEVATED BLOOD PRESSURE (BP). IT WAS ALSO FOUND THAT YOGA IS USEFUL IN REDUCING RAISED BP. THUS, THEY BOTH CAN BE USED IN PREVENTION AND TREATMENT OF HYPERTENSION. HENCE, THE STUDY AIMED TO OBSERVE BOTH AWARENESS AND PRACTICE OF AEROBIC EXERCISE AND YOGA AMONG HYPERTENSIVE PATIENTS IN ANAND CITY. MATERIALS AND METHODS: A CROSS-SECTIONAL DESCRIPTIVE STUDY WAS CONDUCTED. A QUESTIONNAIRE WAS PREPARED CONTAINING 24 QUESTIONS ABOUT AWARENESS AND PRACTICE OF AEROBIC EXERCISE AND YOGA AMONG HYPERTENSIVE PATIENTS. THE QUESTIONS WERE EXPLAINED TO ALL THE PATIENTS, AND 200 PATIENTS WERE RECRUITED FROM ANAND CITY THROUGH CONVENIENCE SAMPLING. RESULTS: TWO-HUNDRED PATIENTS WERE INCLUDED IN THIS STUDY, OF WHICH 100% WERE AWARE OF HYPERTENSION. 67.68% WERE AWARE OF THE ROLE OF AEROBIC EXERCISE IN HYPERTENSION, OF WHICH 58.29% PRACTICED THEM. THE AWARENESS OF THE ROLE OF YOGA IN HYPERTENSION WAS NOTED IN 33.67% OF PATIENTS, OF WHICH ONLY 13.07% PRACTICED PRANAYAMA AND 9.50% PRACTICED ASANAS. CONCLUSION: THERE WAS A COMPLETE AWARENESS OF HYPERTENSION AMONG HYPERTENSIVE PATIENTS. A LARGE NUMBER OF PATIENTS WERE AWARE OF THE ROLE OF AEROBIC EXERCISE IN HYPERTENSION, BUT ONLY FEW OF THE PATIENTS PRACTICED THEM. HOWEVER, THERE WAS LESS AWARENESS OF THE ROLE OF YOGA IN HYPERTENSION AND EVEN LESSER NUMBER PRACTICED THEM. 2019 16 1081 48 EFFECTS OF YOGA ON SEXUAL FUNCTION IN WOMEN WITH METABOLIC SYNDROME: A RANDOMIZED CONTROLLED TRIAL. INTRODUCTION: FEMALE SEXUAL DYSFUNCTION IS AN IMPORTANT PUBLIC HEALTH ISSUE; IT HAS A HIGH GLOBAL PREVALENCE, BUT NO EFFECTIVE AND SAFE TREATMENT OPTIONS. THE PREVALENCE OF SEXUAL DYSFUNCTION IS HIGHER IN WOMEN WITH METABOLIC SYNDROME THAN IN THE GENERAL POPULATION. AIM: THE AIM OF THIS STUDY WAS TO INVESTIGATE THE EFFICACY OF YOGA AS A TREATMENT FOR SEXUAL DYSFUNCTION IN WOMEN WITH METABOLIC SYNDROME. METHODS: IN THIS RANDOMIZED, CONTROLLED STUDY, 41 WOMEN WITH METABOLIC SYNDROME (AGE 30-60 YEARS) WERE ASSIGNED TO A 12-WEEK YOGA EXERCISE GROUP (N=20) OR A WAIT-LISTED CONTROL GROUP (N=21). MAIN OUTCOME MEASURES: PRIMARY END POINTS WERE CHANGES IN TOTAL AND INDIVIDUAL DOMAIN SCORES ON THE FEMALE SEXUAL FUNCTION INDEX. RESULTS: THE 12-WEEK YOGA INTERVENTION RESULTED IN SIGNIFICANT IMPROVEMENT IN AROUSAL (0.74+/-1.18 VS. 0.16+/-0.82, RESPECTIVELY; P=0.042) AND LUBRICATION (0.72+/-1.12 VS. 0.06+/-0.87, RESPECTIVELY; P=0.008) COMPARED WITH THE CONTROL GROUP. SYSTOLIC BLOOD PRESSURE SHOWED SIGNIFICANTLY GREATER IMPROVEMENT IN THE YOGA GROUP THAN IN THE CONTROL GROUP AT THE 12-WEEK FOLLOW UP (-3.5+/-13.7 VS. 2.0+/-14.7, RESPECTIVELY; P=0.040). CONCLUSION: THESE FINDINGS SUGGEST THAT YOGA MAY BE AN EFFECTIVE TREATMENT FOR SEXUAL DYSFUNCTION IN WOMEN WITH METABOLIC SYNDROME AS WELL AS FOR METABOLIC RISK FACTORS. 2013 17 328 48 ANTIHYPERTENSIVE EFFECTS OF YOGA IN A GENERAL PATIENT POPULATION: REAL-WORLD EVIDENCE FROM ELECTRONIC HEALTH RECORDS, A RETROSPECTIVE CASE-CONTROL STUDY. BACKGROUND: DESPITE DECADES OF RESEARCH AND ESTABLISHED TREATMENT STRATEGIES, HYPERTENSION REMAINS A PREVALENT AND INTRACTABLE PROBLEM AT THE POPULATION LEVEL. YOGA, A LIFESTYLE-BASED PRACTICE, HAS DEMONSTRATED ANTIHYPERTENSIVE EFFECTS IN CLINICAL TRIAL SETTINGS, BUT LITTLE IS KNOWN ABOUT ITS EFFECTIVENESS IN THE REAL WORLD. HERE, WE USE ELECTRONIC HEALTH RECORDS TO INVESTIGATE THE ANTIHYPERTENSIVE EFFECTS OF YOGA AS USED BY PATIENTS IN THEIR DAILY LIVES. METHODS: A RETROSPECTIVE, OBSERVATIONAL CASE-CONTROL STUDY OF 1815 RECORDS AMONG 1355 YOGA EXPOSED PATIENTS AND 40,326 RECORDS AMONG 8682 YOGA NON-EXPOSED PATIENTS COLLECTED BETWEEN 2006 AND 2016 FROM A REGIONAL ACADEMIC HEALTH SYSTEM. LINEAR MIXED-EFFECTS MODELS WERE USED TO ESTIMATE THE AVERAGE TREATMENT EFFECT OF YOGA ON SYSTOLIC AND DIASTOLIC BLOOD PRESSURES. MIXED EFFECTS LOGISTIC REGRESSION MODELS WERE USED TO CALCULATE ODDS RATIOS FOR YOGA USE AND FOUR BLOOD PRESSURE CATEGORIES: NORMAL, ELEVATED, STAGE I, AND STAGE II HYPERTENSION. RESULTS: YOGA PATIENTS ARE PREDOMINANTLY WHITE (88.0%) AND FEMALE (87.8%) WITH MEDIAN AGE 46 YEARS (IQR 32-57) WHO USE YOGA ONE TIME PER WEEK (62.3%). YOGA IS ASSOCIATED WITH LOWER SYSTOLIC (- 2.8 MMHG, STANDARD ERROR 0.6; P < .001) AND DIASTOLIC (- 1.5 MMHG, STANDARD ERROR 0.5; P = 0.001) BLOOD PRESSURES. PATIENTS USING YOGA HAVE 85% INCREASED ODDS (OR 1.85, 95% CI 1.39-2.46) OF HAVING NORMAL BLOOD PRESSURE RELATIVE TO YOGA NON-EXPOSED PATIENTS. PATIENTS AGED 40-59 YEARS HAVE 67% DECREASED ODDS (0.33, 95% CI 0.14-0.75) OF HAVING STAGE II HYPERTENSION. ALL EFFECT SIZES ARE AGE-DEPENDENT. CONCLUSIONS: YOGA, AS USED BY PATIENTS IN THEIR DAILY LIVES, MAY BE AN EFFECTIVE STRATEGY FOR BLOOD PRESSURE CONTROL AND THE PREVENTION OF HYPERTENSION AT THE POPULATION LEVEL. 2022 18 270 53 ADD ON YOGA TREATMENT FOR NEGATIVE SYMPTOMS OF SCHIZOPHRENIA: A MULTI-CENTRIC, RANDOMIZED CONTROLLED TRIAL. THE EFFICACY OF ANTIPSYCHOTIC MEDICATIONS IN THE TREATMENT OF NEGATIVE SYMPTOMS OF SCHIZOPHRENIA IS MODEST AT BEST. PRELIMINARY STUDIES SUGGEST THE BENEFICIAL EFFECTS OF ADD ON YOGA, A TRADITIONAL INDIAN PRACTICE, IN THE TREATMENT OF SCHIZOPHRENIA. HENCE, IN THIS STUDY, WE EXAMINED THE EFFICACY OF YOGA AS AN ADD-ON TREATMENT FOR NEGATIVE SYMPTOMS OF SCHIZOPHRENIA IN A RANDOMIZED, WAIT-LIST CONTROLLED DESIGN FROM TWO CLINICAL INSTITUTES IN SOUTH INDIA. 89 PATIENTS (AGE - 34.20 +/- 8.06 YEARS; EDUCATION - 14.22 +/- 2.69 YEARS; 28 FEMALES) WERE RANDOMIZED INTO THE ADD-ON YOGA OR TREATMENT AS USUAL (TAU - WAIT-LIST CONTROL) GROUP. PATIENTS HAD A MEAN ILLNESS DURATION OF 10.97 +/- 7.24 YEARS WITH AN AGE AT ONSET OF 23.34 +/- 5.81 YEARS. CENTRAL BLOCK RANDOMIZATION WAS FOLLOWED TO ENSURE CONCEALED ALLOCATION. PARTICIPANTS RANDOMIZED TO THE YOGA TREATMENT GROUP ATTENDED 12 SUPERVISED YOGA TRAINING SESSIONS OVER TWO WEEKS AND PRACTICED YOGA SESSIONS AT HOME FOR THE SUBSEQUENT 10 WEEKS. 64 PATIENTS COMPLETED THE TRIAL. AN INTENT TO TREAT ANALYSIS WAS CONDUCTED WITH 89 PARTICIPANTS USING A LINEAR MIXED MODEL. IMPROVEMENT IN NEGATIVE SYMPTOMS WAS OUR PRIMARY OUTCOME MEASURE. THE TWO GROUPS WERE MATCHED ON DEMOGRAPHIC VARIABLES AND BASELINE PSYCHOPATHOLOGY SEVERITY. PARTICIPANTS IN THE ADD-ON YOGA GROUP HAD SIGNIFICANTLY GREATER IMPROVEMENT IN NEGATIVE SYMPTOMS (SANS BASELINE: 49.13 +/- 2.30; 12-WEEKS FOLLOW UP: 31.55 +/- 2.53) COMPARED TO THE TAU GROUP (SANS BASELINE: 51.22 +/- 2.40; 12-WEEKS FOLLOW UP: 45.30 +/- 2.93; T = 3.36; P = 0.006; COHEN'S D-0.65). THE CURRENT STUDY FINDINGS SUGGEST THE EFFICACY OF YOGA AS AN ADD-ON TREATMENT FOR NEGATIVE SYMPTOMS OF SCHIZOPHRENIA. THE EFFECTIVENESS OF YOGA PRACTICE AS A REGULAR CLINICAL INTERVENTION FOR PATIENTS NEEDS TO BE EXPLORED IN FUTURE STUDIES BY INTEGRATING YOGA SERVICES ALONG WITH OTHER CLINICAL SERVICES. 2021 19 1366 41 IMPACT OF A 10 MINUTE SEATED YOGA PRACTICE IN THE MANAGEMENT OF DIABETES. OBJECTIVE: WE SOUGHT TO PROSPECTIVELY EVALUATE THE IMPACT OF A 10 MINUTE SEATED YOGA PROGRAM ADDED TO STANDARD COMPREHENSIVE DIABETES CARE ON GLUCOSE CONTROL AND CARDIOVASCULAR HEALTH IN THE SEVERELY ILL, MEDICALLY COMPLEX DIABETIC POPULATION. METHOD: A TOTAL OF 10 PATIENTS WITH TYPE 2 DIABETES, AGES 49-77, WITH DURATION OF DIABETES >10 YEARS AND HAEMOGLOBIN A1C >9% (75 MMOL/MOL) WERE INCLUDED IN THE STUDY. PATIENTS RANDOMIZED TO A YOGA INTERVENTION WERE TAUGHT A 10 MINUTE SEATED YOGA PRACTICE, WERE GIVEN AN EXPLANATORY DVD AND A FOLD-OUT POCKET GUIDE TO ENCOURAGE ADHERENCE AT HOME, AND WERE INSTRUCTED TO INCORPORATE THE PRACTICE AS OFTEN AS THEY COULD. THE PATIENTS IN THE CONTROL ARM WERE PROVIDED INFORMATION AND HAND OUTS ON THE AVAILABLE YOGA CLASSES ON CAMPUS. RESULTS: AT 3 MONTH CLINICAL FOLLOW UP, THE MEAN DECREASE IN FASTING CAPILLARY BLOOD GLUCOSE (CBG) WAS 45% AMONG YOGA PARTICIPANTS (-5.2 +/- 4.1 MMOL/L). HEART RATE (HR) DROPPED BY 18% AND DIASTOLIC BLOOD PRESSURE (BP) DROPPED BY 29% IN THE INTERVENTION ARM, (-12.4 +/- 6.69 AND -26 +/- 12.05 MMHG, RESPECTIVELY). THERE WERE NO STATISTICALLY SIGNIFICANT CHANGES IN THE HAEMOGLOBIN A1C, SYSTOLIC BLOOD PRESSURE, WEIGHT, OR BODY MASS INDEX IN EITHER GROUP. CONCLUSION: OUR SMALL PILOT STUDY REINFORCES THE CURRENT MEDICAL EVIDENCE SUPPORTING THE USE OF YOGA, COMBINED WITH STANDARD CARE, TO IMPROVE HEALTH OUTCOMES IN DIABETES. 2016 20 1818 45 PROSPECTIVE RANDOMIZED TRIAL OF STANDARD ANTIEMETIC THERAPY WITH YOGA VERSUS STANDARD ANTIEMETIC THERAPY ALONE FOR HIGHLY EMETOGENIC CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN SOUTH ASIAN POPULATION. AIM/BACKGROUND: CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) IS ONE OF THE MOST DISTRESSING SIDE EFFECTS OF HIGHLY EMETOGENIC CHEMOTHERAPY REGIMENS. THERE HAVE BEEN CONTINUOUS EFFORTS IN THE DIRECTION TO CONTROL CINV BY MANY INVESTIGATORS. MATERIALS AND METHODS: RANDOMLY SELECTED PATIENTS WERE THOSE RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY REGIMEN GROUPED INTO YOGA AND STANDARD ANTIEMETIC THERAPY (N = 50) JUST BEFORE RECEIVING CHEMOTHERAPY AND CONTINUED FOR THE FOLLOWING DAYS AND OTHER GROUP (N = 50) RECEIVED ONLY THE STANDARD ANTIEMETIC AGENT. BOTH THE GROUPS WERE ASSESSED, FOLLOWED FOR ACUTE AND DELAYED ONSET OF CHEMOTHERAPY-INDUCED AND ANTICIPATORY NAUSEA AND VOMITING USING RADIATION THERAPY ONCOLOGY GROUP GRADING FOR THE SAME. WE ALSO ASSESSED THE QUALITY OF LIFE OF THE PATIENT USING THE FUNCTIONAL ASSESSMENT OF CANCER THERAPY-GENERAL QUESTIONNAIRE. RESULTS: THE MEDIAN AGE GROUP OF THE PATIENTS WAS 51 YEARS WITH MALE:FEMALE RATIO 2:1, THE EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG) PERFORMANCE STATUS WAS 0/1 IN 38% OF THE SELECTED POPULATION, WHILE ECOG 2 IN 62% OF THE PATIENTS. IN YOGA ARM, INSIGNIFICANT REDUCTION IN CHEMOTHERAPY-INDUCED NAUSEA (90% VS. 78%, P = 0.35) AND BUT SIGNIFICANT REDUCTION IN VOMITING (42% VS. 22%, P =0.01) WAS OBSERVED AS COMPARED TO THE STANDARD ANTIEMETICS ONLY ARM. THERE WAS A SIGNIFICANT REDUCTION IN GRADE 2 AND 3 NAUSEA (84% VS. 38% P < 0.01) AND VOMITING (14% VS. 0% P < 0.01). QUALITY OF LIFE IS ALSO SIGNIFICANTLY IMPROVED IN THE YOGA ARM, ESPECIALLY IN THE ECOG 2 PERFORMANCE STATUS. CONCLUSIONS: THIS STUDY CONCLUDES THAT YOGA ALONG WITH STANDARD ANTIEMETIC MEDICATION SHOULD BE A PART OF THE MANAGEMENT PLAN FOR THE CANCER PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY. 2019